ACDIMA BioCenter for Bioequivalence and Pharmaceutical Studies is one of the multi projects of the Arab Company for Drug Industries and Medical Appliances (ACDIMA) that was founded as a Contract Research Organization (CRO) more than 15 years ago in Amman, Jordan. It employs qualified trained personnel with high level of experience and is well equipped with state of the art bioanalytical and laboratory equipment as well as a modern specialized clinical site.
| Website | http://www.acdimabiocenter.com |
| Revenue | $9.6 million |
| Employees | 103 (66 on RocketReach) |
| Founded | 2000 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+10 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing |
| Keywords | Bioequivalence Studies, Pharmaceutical Studies, Contract Research Organization, Cro Services, Biopharmaceutical Research, Drug Development, Clinical Trials, Regulatory Affairs, Pharmacokinetics, Pharmacodynamics, Bioanalysis, Drug Analysis, Preclinical Studies, Formulation Development, Quality Control, Quality Assurance, Analytical Testing, Medical Research, Pharmaceutical Research, Biotechnology |
| Competitors | Roche, Thermo Fisher Scientific, BD, Merck Group, Agilent Technologies, Charles River Laboratories, Illumina, PerkinElmer, Inc., Bio-Rad Laboratories, QIAGEN +43 more (view full list) |
Looking for a particular ACDIMA BioCenter employee's phone or email?
The ACDIMA BioCenter annual revenue was $9.6 million in 2026.
Rabab Tayyem is the CEO and Executive Director of ACDIMA BioCenter.
66 people are employed at ACDIMA BioCenter.